Silence Therapeutics plc Stock
Stocks
SLN
US82686Q1013
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.95 USD | +1.96% |
|
+13.92% | +96.55% |
| 08-04 | European Equities Traded in US as ADRs Advance in Tuesday Trading | MT |
| 08-03 | European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading | MT |
| Market Cap | 418M 564M 488M 456M 787M 53.72B 799M 5.35B 2.1B 26.93B 2.12B 2.07B 89.01B | P/E 2026 * |
-20x | P/E 2027 * | -17.8x |
|---|---|---|---|---|---|
| Enterprise Value | 272M 368M 318M 297M 512M 34.98B 520M 3.48B 1.37B 17.53B 1.38B 1.35B 57.96B | EV / Sales 2026 * |
108x | EV / Sales 2027 * | 48.9x |
| Free-Float |
69.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Silence Therapeutics plc
| 1 day | +1.96% | ||
| 1 week | +13.92% | ||
| Current month | +13.92% | ||
| 1 month | +17.73% | ||
| 3 months | +71.94% | ||
| 6 months | +151.58% | ||
| Current year | +96.55% |
| 1 week | 10.32 | 12.3 | |
| 1 month | 8.91 | 12.3 | |
| Current year | 4.19 | 12.3 | |
| 1 year | 4.19 | 12.3 | |
| 3 years | 1.97 | 27.72 | |
| 5 years | 1.97 | 27.72 | |
| 10 years | 1.97 | 35 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 01/12/2025 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 01/02/2022 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 21/06/2018 |
Iain Ross
CHM | Chairman | 72 | 01/01/2004 |
Tim McInerney
BRD | Director/Board Member | 65 | 05/05/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/6/26 A | Sell | 865,112 | 0.6105% | |||
| 1/2/26 A | Free | Chief Financial Officer | 375,000 | 0.2646% | ||
| 1/2/26 A | Free | Director | 90,000 | 0.0635% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.96% | +13.92% | +122.12% | +116.09% | 564M | ||
| +0.99% | +1.78% | +4.07% | +16.73% | 49.47B | ||
| +3.71% | +9.40% | +486.98% | +592.14% | 43.61B | ||
| +2.70% | +1.57% | +33.39% | +8.85% | 39.29B | ||
| +5.60% | +10.21% | +16.76% | +85.72% | 39.6B | ||
| +2.21% | +6.75% | +21.31% | +53.37% | 32.43B | ||
| +2.23% | +4.71% | - | - | 16.84B | ||
| +0.97% | +2.35% | +37.75% | +126.84% | 16.49B | ||
| -0.11% | +2.41% | +6.24% | +18.87% | 14.01B | ||
| +0.75% | +15.04% | +78.59% | +30.30% | 12.77B | ||
| Average | +2.10% | +7.08% | +89.69% | +116.55% | 26.51B | |
| Weighted average by Cap. | +2.54% | +6.11% | +104.30% | +140.73% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.51M 3.39M 2.93M 2.74M 4.73M 323M 4.8M 32.15M 12.62M 162M 12.74M 12.46M 535M | 3.47M 4.68M 4.05M 3.78M 6.52M 445M 6.63M 44.36M 17.41M 223M 17.58M 17.19M 738M |
| Net income | -50.4M -68.02M -58.84M -54.94M -94.8M -6.47B -96.31M -645M -253M -3.24B -255M -250M -10.73B | -84.8M -114M -98.99M -92.44M -160M -10.89B -162M -1.08B -426M -5.46B -430M -420M -18.05B |
| Net Debt | -146M -197M -170M -159M -274M -18.74B -279M -1.87B -732M -9.39B -739M -723M -31.05B | -249M -336M -290M -271M -468M -31.95B -475M -3.18B -1.25B -16.02B -1.26B -1.23B -52.95B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | $11.95 | +1.96% | 316,885 |
| 06/08/26 | $11.72 | +4.27% | 252,799 |
| 05/08/26 | $11.24 | +0.63% | 452,234 |
| 04/08/26 | $11.17 | +4.59% | 518,643 |
| 03/08/26 | $10.68 | +1.81% | 536,744 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
Select your edition
All financial news and data tailored to specific country editions

















